The currently available evidence from molecular feature, gene expression, mutation analysis and translational studies suggests that new neurotrophic factor CART (or CARTPT, cocaine- and amphetamine-regulated transcript prepropeptide) has possible therapeutic implications in the treatment of major depression and other mood disorders and comorbid obesity. This evidence concerns the gene CARTPT and obesity disorder.